That downhill slide is reflected in comments from disgruntled BlinkRx prospects in all kinds of other sites. On copyright, where by the assessments are rather evenly break up at 45% five-stars and 39% 1-star (with the warn from copyright expressing that the pharmacy might be stacking the deck with "unsupported invitation solutions”), you'll see r